Labyrinthitis is an inflammatory disorder of the inner ear (membranous labyrinth) that presents as an acute vestibular syndrome (AVS) with both vertigo and unilateral hearing loss, distinguishing it from vestibular neuritis, which spares hearing. [1-3] It is most commonly viral in etiology but can also be bacterial, particularly as a complication of otitis media or meningitis. [2][4-5]
1. History
- Onset and duration: Acute onset of severe, continuous rotational vertigo lasting >24 hours, developing over hours [2][6]
- Hearing: Unilateral hearing loss and/or tinnitus — the key feature distinguishing labyrinthitis from vestibular neuritis [2-3]
- Associated symptoms: Nausea, vomiting, aural fullness, gait unsteadiness
- Prodrome: Recent viral URI (supports viral etiology); ear pain or otorrhea (suggests bacterial/otogenic cause) [2][5]
- Timing and triggers: Continuous (not episodic), not positionally triggered — classifies as AVS [6]
- Important negatives: No focal neurologic deficits (dysarthria, diplopia, dysphagia, limb weakness, numbness), no headache, no loss of consciousness
2. Alarm Features
- Direction-changing nystagmus, vertical nystagmus, or pure torsional nystagmus → suggests central cause (stroke) [7-8]
- Normal head impulse test (HIT) in the setting of AVS → concerning for central etiology [2][7]
- Skew deviation on test of skew → central cause [7]
- New acute hearing loss with AVS — stroke is actually more common than labyrinthitis in this scenario per GRACE-3 data [6]
- Severe truncal ataxia (inability to sit or stand unsupported) → posterior fossa stroke [2][7]
- Sudden onset in a patient with vascular risk factors (HTN, DM, atrial fibrillation, age >50) [8-9]
- Fever, severe otalgia, otorrhea → bacterial labyrinthitis, which can progress to meningitis or intracranial abscess [5]
- Meningeal signs → meningogenic labyrinthitis [4][10]
3. Medications
Acute symptomatic treatment (limit to 3–5 days)
- Vestibular suppressants: Meclizine 12.5–25 mg PO q8h, dimenhydrinate 25–50 mg PO/IV q6h, or diphenhydramine 25–50 mg PO/IV q6h [3][6]
- Benzodiazepines: Diazepam 2–5 mg PO/IV q8h for severe symptoms (short-term only) [3]
- Antiemetics: Ondansetron 4 mg IV/ODT, promethazine 12.5–25 mg IV/IM [3][11]
- Corticosteroids: Consider methylprednisolone taper or prednisone 1 mg/kg for 5 days with taper — evidence is mixed but shared decision-making is recommended per GRACE-3 [6][11]
Cautions
- Vestibular suppressants beyond 3–5 days inhibit central compensation and prolong recovery [6]
- Avoid meclizine in elderly patients (anticholinergic burden per AGS Beers Criteria) [6]
- Antivirals are not effective and not recommended [8][12]
- Bacterial labyrinthitis requires IV antibiotics targeting the causative organism
4. Diet
- Maintain adequate hydration, especially with vomiting
- Low-sodium diet is not specifically indicated for labyrinthitis (unlike Ménière disease) but may be considered if Ménière is in the differential
- Avoid alcohol and caffeine during acute phase (may worsen vestibular symptoms)
5. Review of Systems
- Neurologic: Headache, visual changes, diplopia, dysarthria, dysphagia, facial numbness/weakness, limb weakness or numbness (rule out stroke)
- ENT: Hearing loss, tinnitus, ear pain, ear discharge, aural fullness, recent URI
- Cardiac: Palpitations, chest pain, syncope (rule out cardiac causes of dizziness)
- Psychiatric: Anxiety, panic symptoms (functional dizziness is common)
- Infectious: Fever, neck stiffness, recent meningitis symptoms
6. Collateral History and Family History
- Confirm symptom timeline and functional status from family/witnesses
- History of recurrent ear infections or prior ear surgery
- Family history of Ménière disease, autoimmune inner ear disease, or migraines
- Social context: Occupation (risk of falls), driving status, living situation (safety at home)
7. Risk Factors
- Recent viral upper respiratory infection (most common antecedent) [2]
- Acute or chronic otitis media (otogenic bacterial labyrinthitis) [5][13]
- Bacterial meningitis (meningogenic labyrinthitis — most common route of bacterial spread) [4][10]
- Immunosuppression (increased risk of viral reactivation: HSV, VZV, HHV-6/7) [14-16]
- Cholesteatoma with bony erosion into the labyrinth
- Age 30–60 years; slight female predominance [8]
8. Differential Diagnosis
- Posterior circulation stroke (cerebellar/brainstem infarct) — the cannot-miss diagnosis; up to 25% of AVS presentations in the ED are stroke. New hearing loss with AVS may be more likely stroke than labyrinthitis [6][9][17]
- Vestibular neuritis — same presentation but without hearing loss [2-3]
- Ménière disease — episodic vertigo (20 min–12 h) with fluctuating hearing loss, tinnitus, aural fullness; not continuous >24 h [3]
- Labyrinthine infarction (AICA territory) — sudden vertigo + hearing loss, often with other brainstem signs [2]
- Perilymph fistula — vertigo + hearing loss after trauma or barotrauma [2]
- Vestibular migraine — episodic, migraine history, hearing loss less common [3]
- Vestibular schwannoma — chronic progressive imbalance and asymmetric hearing loss [3]
- Autoimmune inner ear disease — bilateral fluctuating hearing loss, steroid-responsive [3]
9. Past Medical History
- Prior episodes of vertigo or hearing loss (recurrence suggests Ménière or migraine)
- History of otitis media, cholesteatoma, ear surgery
- Vascular risk factors: HTN, DM, atrial fibrillation, hyperlipidemia, smoking (raise concern for stroke)
- Migraine history
- Autoimmune conditions
- Recent meningitis or immunosuppressive therapy
10. Physical Exam
Vital signs: Assess for fever (bacterial cause), hypertension (stroke), orthostatic hypotension
Focused exam
- Otoscopy: Evaluate for otitis media, cholesteatoma, perforation, effusion — critical to identify otogenic labyrinthitis [16]
- Bedside hearing test: Finger rub or whispered voice test for unilateral hearing loss; Weber and Rinne with tuning fork (sensorineural loss lateralizes away from affected ear) [6][8]
- Nystagmus assessment: Expect unidirectional, horizontal-torsional nystagmus beating away from the affected ear; suppresses with visual fixation (peripheral pattern) [2][7]
- Head impulse test (HIT): Positive (corrective saccade) toward the affected side = peripheral; normal HIT in AVS = concerning for central cause [2][7]
- Test of skew: Vertical misalignment = central cause [7]
- Gait assessment: Patients with peripheral lesions can typically stand but veer toward the affected side; inability to stand/sit unsupported suggests central pathology [2]
- Full neurologic exam: Cranial nerves, cerebellar testing (finger-to-nose, heel-to-shin), Romberg
11. Lab Studies
- Routine labs are generally not required for uncomplicated viral labyrinthitis [8][18]
- If bacterial labyrinthitis suspected: CBC, CRP, blood cultures, consider lumbar puncture if meningitis is a concern
- If atypical or recurrent: Consider RPR, HIV, TSH, ANA, ESR [16]
- Viral serologies are not recommended routinely — they cannot prove causation [2][12]
- Glucose/HbA1c if vascular risk factors present [19]
12. Imaging
- CT head: Not recommended routinely — has very low sensitivity for posterior fossa stroke (<1% detection rate with normal neuro exam) and shows no findings in labyrinthitis [6][9]
- MRI brain with DWI: Indicated if central cause is suspected (abnormal HINTS, focal neurologic signs, vascular risk factors, sudden onset). Note: initial DWI can be false-negative in up to 20% of posterior fossa strokes in the first 48 hours [2][8-9]
- MRI with gadolinium (3D FLAIR): Can show labyrinthine enhancement in labyrinthitis [13]
- CT temporal bone: Consider if cholesteatoma, bony erosion, or superior canal dehiscence is suspected [8]
13. Special Tests
- HINTS exam (Head Impulse, Nystagmus, Test of Skew): The cornerstone bedside test for differentiating peripheral from central AVS. Sensitivity 93%, specificity 83% for central causes when performed by trained clinicians. HINTS Plus adds bedside hearing assessment and reaches ~99% sensitivity [7][20]
- Dix-Hallpike maneuver: Should be negative in labyrinthitis (positive suggests BPPV) [8]
- Electronystagmography (ENG)/Videonystagmography (VNG): Can document unilateral caloric hypoexcitability; rarely needed acutely [2]
- Audiometry: Formal audiogram to quantify and characterize hearing loss — important for follow-up [1]
14. ECG
- Obtain ECG if cardiac etiology of dizziness is being considered (arrhythmia, presyncope) [8]
- Specifically indicated if: palpitations, syncope, irregular pulse, or significant bradycardia/tachycardia
- Look for: atrial fibrillation (stroke risk), prolonged QTc, heart block, ischemic changes
- Not routinely required for a clear peripheral vestibular presentation
15. Assessment
Labyrinthitis presents as an acute vestibular syndrome — continuous vertigo >24 hours with spontaneous nystagmus, nausea/vomiting, and gait unsteadiness — plus unilateral sensorineural hearing loss and/or tinnitus. [1-3] The hearing loss component is the defining feature that separates it from vestibular neuritis. Most cases are viral and self-limiting, with vertigo resolving over days to weeks, though hearing loss may be permanent. [3] Bacterial labyrinthitis (otogenic or meningogenic) is less common but carries significant morbidity including risk of permanent deafness and intracranial complications. [4-5][10]
The critical clinical challenge is excluding posterior circulation stroke, which can mimic labyrinthitis and is actually more common than labyrinthitis in patients presenting with AVS plus acute hearing loss. [6][9]
16. Treatment Plan
Initial stabilization
- IV access, IV fluids if dehydrated from vomiting
- Antiemetics: ondansetron 4 mg IV
- Vestibular suppressant: dimenhydrinate 50 mg IV or meclizine 25 mg PO
Pharmacotherapy
- Corticosteroids: Consider prednisone 1 mg/kg/day × 5 days then taper, or methylprednisolone 100 mg tapered over 3 weeks — shared decision-making recommended [6][11]
- Vestibular suppressants: Meclizine 25 mg PO q8h PRN — limit to 3–5 days maximum [6]
- Bacterial labyrinthitis: IV antibiotics (e.g., ceftriaxone ± vancomycin if meningogenic); ENT consultation for possible surgical drainage if otogenic with abscess
Vestibular rehabilitation
- Refer all patients for vestibular rehabilitation therapy — supported by systematic review evidence of efficacy [6]
- Early mobilization and gaze stabilization exercises accelerate central compensation
17. Disposition
Discharge criteria
- Confident peripheral diagnosis (positive HIT, unidirectional nystagmus, no skew, no focal neuro deficits)
- Able to tolerate PO fluids and ambulate safely
- Reliable follow-up arranged
Admission criteria
- Concern for central cause (abnormal HINTS, focal neurologic signs, high vascular risk)
- Suspected bacterial labyrinthitis (fever, otitis media with inner ear involvement, meningeal signs)
- Intractable vomiting/dehydration
- Inability to ambulate safely, especially in elderly or those living alone
Specialist consultation
- Neurology/stroke team: If central cause suspected
- ENT/Otolaryngology: For all labyrinthitis cases (hearing loss evaluation, audiometry, follow-up) [6]
- Vestibular physical therapy: Referral at discharge [6]
18. Follow Up / Return Precautions
Follow-up timing
- ENT/audiology within 1–2 weeks for formal audiometry and vestibular assessment [1][6]
- PCP within 1 week
- Vestibular rehabilitation therapy initiation within 1–2 weeks
Return precautions — instruct patients to return immediately for:
- New neurologic symptoms: slurred speech, facial droop, limb weakness/numbness, severe headache, vision changes
- Worsening vertigo after initial improvement
- High fever, severe ear pain, neck stiffness
- Inability to keep fluids down
Patient counseling
- Acute vertigo typically improves significantly within 3–7 days, with residual imbalance potentially lasting weeks to months [2]
- Hearing loss may be permanent — early audiologic follow-up is essential [1]
- Avoid driving until vertigo has resolved
- Vestibular suppressants should be stopped after 3–5 days to allow central compensation [6]
- BPPV may develop as a sequela in some patients [2]
Images
References
1. Sudden Unilateral Hearing Loss and Acute Vestibular Syndrome: A 5-Year-Old Case With Labyrinthitis. — Aykul Yağcıoğlu A, Ertuğrul G. Journal of the American Academy of Audiology. 2025.
2. Vestibular Neuritis. — Baloh RW. The New England Journal of Medicine. 2003.
3. Clinical Practice Guideline: Ménière's Disease. — Basura GJ, Adams ME, Monfared A, et al. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2020.
4. Labyrinthitis Ossificans in a Cynomolgus Macaque (Macaca Fascicularis). — Balamayooran G, Atkins HM, Whitlow CT, et al. Comparative Medicine. 2018.
5. Inner Ear and Facial Nerve Complications of Acute Otitis Media With Focus on Bacteriology and Virology. — Hydén D, Akerlind B, Peebo M. Acta Oto-Laryngologica. 2006.
6. Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department. — Edlow JA, Carpenter C, Akhter M, et al. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2023.
7. Diagnostic Accuracy of the Physical Examination in Emergency Department Patients With Acute Vertigo or Dizziness: A Systematic Review and Meta-Analysis for GRACE-3. — Shah VP, Oliveira J E Silva L, Farah W, et al. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2023.
8. Dizziness: Evaluation and Management. — Rogers TS, Noel MA, Garcia B. American Family Physician. 2023.
9. ACR Appropriateness Criteria® Dizziness and Ataxia: 2023 Update. — Wang LL, Thompson TA, Shih RY, et al. Journal of the American College of Radiology : JACR. 2024.
10. Pathogenesis of Labyrinthitis Associated With Haemophilus Influenzae Type B Meningitis in Infant Rats. — Wiedermann BL, Hawkins EP, Johnson GS, et al. The Journal of Infectious Diseases. 1986.
11. Corticosteroids for the Treatment of Idiopathic Acute Vestibular Dysfunction (Vestibular Neuritis). — Fishman JM, Burgess C, Waddell A. The Cochrane Database of Systematic Reviews. 2011.
12. Recent Advances in Viral Inner Ear Disorders. — Beyea JA, Agrawal SK, Parnes LS. Current Opinion in Otolaryngology & Head and Neck Surgery. 2012.
13. Direction-Changing Positional Nystagmus in Acute Otitis Media Complicated by Serous Labyrinthitis: New Insights Into Positional Nystagmus. — Choi JW, Han K, Nahm H, Shin JE, Kim CH. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society European Academy of Otology and Neurotology. 2019.
14. Cellular Processes Induced by HSV-1 Infections in Vestibular Neuritis. — Zhao Z, Liu X, Zong Y, Shi X, Sun Y. Viruses. 2023.
15. HHV 6-7 Reactivation Causing Pityriasis Rosea and Labyrinthitis: A Case Report. — El-Hussein M, El-Tawil C, Nakhle R, Souaiby N. The American Journal of Emergency Medicine. 2020.
16. Multidisciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Neurologic Sequelae in Patients With Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). — Melamed E, Rydberg L, Ambrose AF, et al. PM & R : The Journal of Injury, Function, and Rehabilitation. 2023.
17. Head Impulse, Nystagmus, and Test of Skew Examination for Diagnosing Central Causes of Acute Vestibular Syndrome. — Gottlieb M, Peksa GD, Carlson JN. The Cochrane Database of Systematic Reviews. 2023.
18. Dizziness: Approach to Evaluation and Management. — Muncie HL, Sirmans SM, James E. American Family Physician. 2017.
19. Blood Biomarkers for the Differentiation Between Central and Peripheral Vertigo in the Emergency Department: A Systematic Review and Meta-Analysis. — Klokman VW, Koningstein FN, Dors JWW, et al. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2024.
20. Differentiating Central From Peripheral Causes of Acute Vertigo in an Emergency Setting With the HINTS, STANDING, and ABCD2 Tests: A Diagnostic Cohort Study. — Gerlier C, Hoarau M, Fels A, et al. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2021.